Tapinarof: AhR Agonist for Psoriasis and Atopic Dermatitis

Overview / Definition Tapinarof is a topical therapeutic agent that functions as an aryl hydrocarbon receptor (AhR) agonist. It is primarily indicated for the treatment of chronic inflammatory skin diseases, particularly psoriasis and atopic dermatitis. Tapinarof’s unique mechanism of action allows it to modulate immune responses and enhance skin barrier function, making it a valuable addition to the dermatological pharmacopoeia. Epidemiology Psoriasis affects approximately 2-3% of the global population, while atopic dermatitis impacts around 10-20% of children and 1-3% of adults. Tapinarof addresses the needs of patients who may be inadequately controlled with traditional therapies, particularly those concerned about the long-term use of topical corticosteroids. Pathophysiology / Mechanism The pathophysiology of psoriasis and atopic dermatitis involves chronic inflammation characterized by the activation of the immune system, particularly the T-helper 1 (Th1) and Th2 cell responses. Tapinarof exerts its effects through the following mechanisms: Activation of AhR leads to the modulation of cytokine production. Induction of anti-inflammatory cytokines, such as IL-10. Promotion of skin barrier repair and maintenance. Reduction of keratinocyte proliferation. This multifaceted mechanism helps to alleviate the symptoms associated with psoriasis and atopic dermatitis. Clinical Presentation Patients with psoriasis typically present with well-defined, erythematous plaques covered with silvery-white scales, commonly found on extensor surfaces, scalp, and lower back. In contrast, atopic dermatitis is characterized by: Pruritic, erythematous patches, typically located on flexural areas. Dry, scaly skin that may exhibit lichenification with chronic scratching. Potential secondary infections due to skin barrier disruption. Both conditions can significantly impact the quality of life and may be associated with comorbidities such as depression, anxiety, and metabolic syndrome. Dia